干细胞之家 - 中国干细胞行业门户第一站

标题: 干细胞移植常用生物学词汇 [打印本页]

作者: fellc    时间: 2008-12-27 14:20     标题: 干细胞移植常用生物学词汇

2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸2 k# |7 L! s3 x% g8 a
2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷& r" G4 N& h% [! A2 c! q
3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷
1 l6 K$ n3 J* _" d( q* Q5-Aza:5-azacytidine,5-氮(杂)胞苷6 Y" z! r8 c' e1 ]3 D
a2-PI:a2-antiplasmin, a2-纤溶酶原抑制物
3 ^: S$ E% z& [0 YAA:aplastic anemia,再生障碍性贫血
- f1 h; w# o. ]7 y+ y  }AAV:adeno-associated virus,腺病毒相关病毒
: L; {9 l7 g* j1 ]$ z( iAb:antibody,抗体
! t. N; d  r. p, C9 nABC:avidin-biiotin complex method, 亲和素生物素复合物法% O5 M7 W, d  m/ [; v
ABMT:autologous bone marrow transplant,自体骨髓移植
- [: l6 X3 U! w/ _/ W  LAc:accessory cell,辅佐细胞
; T3 }, ^% G  c: Y( [3 @' nACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖
. r% E* |+ \5 T' [, _5 WACP:acid phosphatase,酸性磷酸梅6 z! E9 ]" \1 e7 X9 v, O  ~2 E
ACTD:actinomycin D,放线菌素D
1 E( u$ f, o- P. e5 [: w3 X9 LAcute:急性的 3 [$ D9 v% _: v
ACV:cyclovir,阿昔洛韦
; X$ E0 K3 c$ t% U( P1 s* VAd:adenovirus,腺病毒
% u2 `0 M" h) o( u& R5 bAD:antigen determinant,抗原决定簇2 N  L) E+ g! u: S; p3 r9 ]5 w1 g
ADA:adenosine deaminase,腺苷脱氨酶' H+ \+ D7 Y9 K4 a0 n- a/ [: A
ADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性4 Q5 I  O5 p7 o2 Z' u
Adjuvant therapy:辅助治疗6 q3 ?( F2 w# u  [6 w% e
AEL:acute erythrocytic leukemia,急性红白血病
, l/ L+ X( H+ u0 BAEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病
+ K, p0 \, ~2 |3 y& O2 ^& VAFP:alpha fetoprotein,甲胎蛋白9 T" S4 B# o! F) C, M) s
Ag:antigen,抗原
: h# s$ C- i! b0 T! U4 baGVHD:acute graft versus host disease,急性移植物抗宿主病6 v, `7 r9 R5 p: z3 e8 B
Aid:anti-idiotype antibody,抗独特型抗体
& l2 _. X! p5 |4 |: \! z$ \  qAidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征! o) {  _7 `4 J! q
AIF:apoptosis-inducing factor,凋亡诱导因子
4 g8 B, \7 ]0 _( G; w8 IAIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血( n$ Y/ ~9 ^' Z* x" x7 v, i
AL:acute leukemia, 急性白血病
  i2 u* a; s6 u$ F$ e  FALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤
6 z, l. x0 |5 Z) t% S0 XALG:antilymphocyte globulin, 抗淋巴细胞球蛋白
8 n3 o* w. K+ LALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位
% n2 c" k+ [/ n' e8 {! }5 ?8 |* lALL:acute lymphocytic leukemia,急性淋巴细胞白血病. b+ k3 A2 I6 h! v  {; c, V
Allo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植1 s2 X* Z( T5 X: e2 _
Allo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植
) U; t& M* u; B, r8 \( z2 HAllogeneic:异基因的
: t1 q; q# i3 T2 x4 n( y" l" _Allograft:异体移植物 6 i( L- G9 g! d5 [
Alopecia:脱发- I; m7 `  u* l/ x4 K
ALP(AKP):Alkaline phosphatase,碱性磷酸酶
7 l& I& G( K: {" E& p4 AAM:adhesion molecule,粘附分子2 h1 B7 X3 S% e9 f. x4 \% U) a5 A
AMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病
1 i) p- Z! y" }9 YAML:acute myeloid leukemia,急性髓性白血病8 @9 z. t- L9 M* `5 p0 {1 E  r
AMM:agnogenic myeloid metaplasia,特发性髓外化生. g+ E$ D. d" r* Z
ANA:antinuclear antibody,抗核抗体 5 B) l7 r. d; D7 c- f
Ana-LL:anaplastic large cell lymphoma,大细胞淋巴瘤  h' g0 ]  N( ^+ y4 ?
Anaphylaxis:过敏症
7 Q+ g8 K' D6 c3 ]* L( y$ v
4 C$ k- Q! I9 |- `9 bANC:absolute neutrophil count,中性粒细胞绝对值
) O: g- P! j$ X% G) j1 [, jAnemia:贫血1 j7 B+ _) l6 `9 w8 Y8 K
ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病9 x+ B5 m7 {/ i4 |( g7 L8 _3 U' u' \* N
Antibiotic:抗生素;抗生的 5 x! r& T3 ?4 S* ?: c
Antiemetic:止吐剂,止吐药
5 p# Y, L1 A% ^, i. Cantineoplastic drugs:抗肿瘤药物: S4 X, j5 I: }% a: j. p5 Q
Antisense:反义引物
6 s9 I: R+ a/ |! `$ k( yAPBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植$ P! X( w$ \$ C* v3 T9 d/ z; I
APC:antigen processing cell,抗原呈递细胞0 F7 F2 a( U2 Q+ S
Apheresis:血浆分离置换法,血液成分部分清除
& i8 S. z4 h: F: f5 H2 @0 [4 oAPL:acute promyelocytic leukemia,急性早幼粒细胞白血病
# f4 J7 n  r7 N  x1 d6 z4 R/ gAplasia:发育不良,成形不完全
+ P& |3 W* U6 N3 e- qApoptosis:凋亡
( z' A) D6 S; H  ~  d/ y9 L; f% DAra-C:arabinosyl cytosine,aracytidine阿糖胞苷! H0 x4 E; O' d# _- A- m
ARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病( c( G# P( r" Z" l1 a. }" L
Ascites:腹水 . i* a( ^# Q2 }8 _# J4 Q9 o! C. H( D0 q
ASCT:autologous stem cell transplantation,自体干细胞移植6 g: T" e! I8 k
Aspergillus:曲霉属
, n. M% b  C% V4 F$ J% p" D3 _ASS:anterior superior spine,髂前上棘
0 z$ |: H& F1 h. v- QAT1257:nitrocaphane,消瘤芥
; r2 p& g7 j% n! n" y9 p: zATG:antithymocyte globulin,抗胸腺细胞球蛋白, M- D$ C! O% d
ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤
- S  D+ w9 {8 ^7 [2 x  k7 Z0 OATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征4 @! W* p2 g, l4 C0 D
ATRA:all-transretinoic acid,全反式维甲酸
* [2 G: I* A' M0 F) XAUL:acute undifferentiated cell leukemia,急性未分化细胞白血病9 t# ]) j3 v" I5 J" @, N
AuSCT: autologous stem cell transplantation,自体造血干细胞移植
' L9 H, _7 M, a8 cAutologous:自体的
- q% g/ Z- j1 h4 r8 N$ E6 vAutograft:自体移植物 / e+ J3 w8 `1 Q6 r. g( m
Auto-BMT: autologous bone marrow transplantation,自体骨髓移植0 }& P% a: b# n" N4 v" Z! v+ P
β2-MG:β2-microglobulin,β2-微球蛋白
, J6 x9 J8 J7 A/ A# ]5 {5 B! }, i7 qBack-up:备份) Z$ Z+ l8 |5 }, o6 M, V
BCNU:Carmustine,卡氮芥,卡莫司汀  |( n" h+ z" K5 |
BCR:breakpoint cluster region,断裂点丛集区
* n0 }  G5 b8 f- t' V# _( cBFU-E: burst-forming unit-erythroid,早期红系集落生成细胞
* _/ G, D- ~) ~0 ], b& _- Z: {Biopsy:活检
; g  N7 S$ {5 \$ R2 [8 }Blast cell:原始血细胞,母细胞
+ U' F2 `( N' m' Z, sBlast-CFC:blast colony forming cell,原始细胞集落形成细胞
$ v6 S& P6 K4 n/ ~Blast crisis:原始细胞危象 / u( R# e  p3 b! p
Bm:memory B lymphocyte,记忆B淋巴细胞1 S1 Y  Q! p( g
BMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病
4 m* ^7 H( D$ M- i( ^) S% lBMT:bone marrow transplantation,骨髓移植
, P9 S) d8 p2 }* R1 ]Bone marrow biopsy:骨髓活检2 k2 C  a- D! ?& I) w, ?; W) p1 ^
Bone marrow puncture:骨髓穿刺
; E. z4 x$ l4 W5 j8 e# nBone marrow smear:骨髓穿刺涂片
/ W( @. Q$ r. U. S* yBRM:biological response modifier,生物应答调节剂. U  ]% v1 O0 p7 E. m
Bu:busulfan,白消安,马利兰 * T; m! ^9 X/ i
Buffer:缓冲,缓冲剂,缓冲液
' }! l( f" M0 N4 r5 l5 Q! {CALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原
/ z1 i8 R) d- p4 C7 M% ICAM:cell adhesion molecule,细胞粘附分子+ ]3 C+ N( G! X' o1 m
Candida:念珠菌属,假丝酵母属
) D+ L8 a8 T2 r; f+ Q" JCatheter:导管 " D2 V  l% K8 w! S$ _1 k, Y! |7 \
CB:cord blood,脐带血
  X) y1 b9 W0 t3 @  G% J0 JCB1348:chlorambucil:苯丁酸氮芥) r) `  p4 L- X2 Y( K' y/ m, Z9 P7 D
CBC:complete blood count,全血细胞计数
4 u2 ]; R# K5 D% a6 P( ^CBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤
# _: ?, B" f2 x8 o  {9 h$ e) m; CCBSCT:cord blood stem cell transplantation,脐血干细胞移植
' F- @+ T0 C# R2 y! y/ E0 i% C* B6 tCCI:corrected count increment,校正增值计数
0 d) T1 u0 A  @: R' I* ZCCNSA:cell cycle non-specific agents,细胞周期非特异性药物 " e1 v& [" _4 {. G7 d. L
CCNU:lomustine,洛莫司汀,环己亚硝脲
+ C% ?; E9 _  z0 OCCR:continuous complete remission,持续完全缓解
/ B5 Y3 d9 i$ M" C$ i7 [/ v. UCCSA:cell cycle specific agents,细胞周期特异性药物
' y. P8 x8 v: G6 i( @  ]. sCD:Castleman's disease,Castleman病  H8 c1 D+ z% n7 R1 m0 T: P7 l
CD:cluster of differentiation,分化群0 j" h, Y5 ], Z# m7 o$ R
CD3AK:CD3 activated killer,CD3激活的杀伤细胞
2 k& a/ p1 P! G1 _' @CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶, p* q% G& E; ?% g6 l# Y; O! a
CEA:carcinoembryonic antigen,癌胚抗原
, o4 u3 G/ N0 ?CEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
$ p4 y+ q7 ^& z1 }, i# a' l$ uCentral line:中心静脉导管,见central venous catheter.
! m3 j& ^* ]. t! l/ jCentral venous catheter: 中心静脉导管,又叫做central line,Hickman catheter 6 q' |  ~% L3 C8 |
Centrifugation:离心
2 K4 z5 S: V0 D! sCFC:colony-forming cell,克隆形成细胞
& H+ ?1 _. o* n& w% W( r6 Q6 gCFU:colony-forming unit,集落形成单位
: ?8 S& j$ F2 d% _' kCFU-Blast:colony-forming unit-Blast,原始集落生成细胞; y( M+ T5 s2 M, I
CFU-E:colony-forming unit-erythroid,红系集落生成细胞: N; w) F) ]6 N% I: ~' ]# h
CFU-G:colony-forming unit-granulocyte,粒系集落生成细胞
* w' y, V3 @' ]CFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞% n6 K5 C- Y, r; A; @! U
CFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位5 S  b% _) G% _8 Y7 K; y1 X
CFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞
; e& L( @; {4 _( x) @CGD:chronic granulomatous disease,慢性肉芽肿病
7 U+ a1 o6 j4 N* O" x- R) Y, p) v6 GCGP:circulating granulocyte pool,循环粒细胞池! h' ^/ [; O, f, a
cGVHD:chronic graft versus host disease,慢性移植物抗宿主病
7 H% ?& p( d& o& gChemo-responsive:化疗敏感的
4 i' n( X9 b; f" _& `Chemotherapy:化学疗法 ( _8 b4 X) L: I4 ~+ Z' A
Chronic慢性的
0 R; F: p0 F" F) cC.I.:continuous infusion,持续静脉点滴, Z4 j: \# S9 i* @8 d
CIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞
/ e' s9 D. u1 }2 T* h% |8 q# i$ iCliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统6 E6 Q% i  T: q9 C0 ]- ?! s0 y
CLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病5 R5 m/ T/ b3 V4 o) g
CML:chronic myelogenous leukemia,慢性粒细胞白血病( L# z3 v! J7 Q( b# o
CML-AP:CML-accelerated phase,慢性粒细胞白血病加速期
$ @3 V' a+ M- h/ L- K4 ]. H6 XCML-BP:CML-blastic phase,慢性粒细胞白血病急变期3 k2 l  Z. Y) U0 x) R; I* ~) |
CML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
5 Y# F# N# _- y2 L4 |& f8 xCMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病/ z7 {" l9 S" S# f0 C' `  r
CMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病0 \8 _% \1 A, n/ d0 ]" U# V
CMV:cytomegalovirus,巨细胞病毒
. c/ H3 R9 ]" f! E# y: uCNR:cytokine negative response cell,细胞因子不反应细胞& V7 `* k9 I# {" |. V& t: X- o
CNS:central nervous system,中枢神经系统. M2 _3 L4 M& G' i5 K
CNSL:central nervous system leukemia,中枢神经系统白血病
1 D/ J- [' t5 j: \Collection: 采集( Y3 R; M: N# z+ b; ~
Colony stimulating factor:集落刺激因子 * ]" k6 b8 W1 y- [! c4 E
c-onc:cellular oncogene,细胞癌基因
, A! q) I' V. L/ `Conditioning:预处理 ( y% d2 U8 Z8 @# |- |2 g$ `
Conjunctivitis:结膜炎
$ ^# W: P9 p" k8 hConvalescence:恢复,恢复期* o* w& M) \0 a7 E
CP:cancer procoagulant,癌性促凝物质
; d; L+ r1 A6 B: [. o/ T/ q  VCPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖
! K9 g1 ]) D$ ]# A7 M9 h( d6 ~CPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤
. O+ R7 m5 L, a" ^, xCpmax:peak concentration,峰浓度: T$ ]$ ]0 u7 A' \4 q; J0 Y6 F
CPT:camptothecine,喜树碱
, Z- t2 y9 Y0 @% @CR:complete remission,完全缓解
% A/ M* P& p; s7 D% @3 ~+ D% B  l( ?CRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白
7 W+ _/ k' E# O* D. S1 y0 q: O  UCRP:C reaction protein,丙反应蛋白
& V& G1 Q6 d+ f# p! U6 iCRR:complete remission rate,完全缓解率
4 c, a: d3 O1 Q2 [' l3 TCryopreservation:冷冻保存,深低温保藏
( S* _5 h2 B* o) E) |: DCSF:colony stimulating factor,集落刺激因子
# z- _9 ]6 {3 C. ?( HCSF:cerebrospinal fluid,脑脊液
4 H% R3 D3 H, J8 R; {8 c* V+ N$ ]CTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤8 a6 K) ~# S5 F5 Q
CTCL:central T cell lymphoma,中枢T细胞淋巴瘤" X  [& s1 f9 |  \; T9 Y4 R) p) r
CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞
* S. Q8 k, F; Y+ \# I% q' qCyclin:周期素" K/ }6 }" k( I1 r% {' L3 z
Cytomegalovirus:巨细胞病毒
0 b/ j, a$ f' K7 c' S  RDC:dendric cell,树突细胞- }" W6 H. {/ W  ~* M# e* |
D-D:D dimer,D-二聚体* f1 {: s& f8 I( }+ [' V- S/ Q
Del:deletion,缺失
1 ?7 v% Y1 ]% f; A3 P/ z( d( Y3 RDermatitis:皮炎
  z: ^3 l4 ?; j  A5 ]' q! tDe nova AML:非继发性急性髓性白血病 5 R& \  G: }1 M, Q: Q3 c
DFS:disease free survival,无病生存期
7 |5 M5 I8 K, D: E( A5 s/ rDI:DNA index,DNA 指数0 v: S9 q8 V( l
DIC:disseminated intravascular coagulation,播散性血管内凝血2 |4 ^2 G9 u7 q" k+ p! Z& J
Dilution:稀释
) H) U6 A- O. c+ c. ZDL:discordant lymphoma,混杂型淋巴瘤' s4 s# h4 y$ @3 T  y1 d2 D$ n( I
Donor:供者
; J5 k! ?# c& ]8 T1 m/ T9 p2 {Dysplasia:发育不良,发育异常
. u7 l/ N( W/ v# v: iEBV:Epstein-Barr virus,EB病毒! v) @- E% n! @
ECM:extracellular matrix,细胞外基质
* H; I8 m( a3 W/ T! b-ectomy:(后缀)(外科)切除,除去,去掉
$ t, C6 }! P. n" N, a9 x; ~% UEdema:水肿 ( k8 T2 `  N' Z7 N' }( n
EGF:epithelial growth factor,表皮生长因子
" q3 n* z+ k1 r* l( @-emia:(后缀)血液疾病 - p! ?4 w: C5 n$ Y- B. h0 _3 v
Encephalopathy:脑病
8 t$ o5 P- x$ T4 W# o0 b" l/ rEncode: 编码
% o( j/ V: D& Y3 VEngraftment:移植物植入
- p6 b& _& b' I% t7 yEnrich:富集& f; b6 x/ l( U/ `0 Y
Enzyme:酶
5 U3 Y4 t3 z9 ?! j) tEosinophil:嗜酸性粒细胞+ z. a2 ]& N7 ?" U9 ?
EPO:erythropoietin,促红素,红细胞生成素, W; E& `3 u9 q/ N& a0 H2 F' \8 q
ETT:essential thrombocythemia,原发性血小板增多症4 s% g; C! J2 N8 n1 ?7 y, \+ Q
Ex vivo:体外   ]( H' s- p) ~6 ~5 Q3 ~
FACS:fluorescence activated cell sorting,荧光活化细胞分选系统$ ^) j; d% |0 {& Q- i( v) T# E/ @" `
FCM:flow cytometry,流式细胞分析技术
+ t6 m3 g6 W/ iFDC:follicular dendritic cells,滤泡树突状细胞
" W5 {+ Z+ R# S5 V8 w) I/ {FDGF:fibroblast derived growth factor,成纤维细胞源生长因子 % N: G$ J; P# f# M
Febrile:发热的 5 Q8 z# o7 r0 L1 h) S& A* a
FFP:fresh frozen plasma,新鲜冰冻血浆7 v! [. ^  \8 r/ W
FGF:fibroblast growth factor,成纤维细胞生长因子# k6 B* ~& I# O1 W; E7 K
FHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症3 E. u9 p$ q( W. N5 J' ^
FISH:fluorescence in situ hybridization,荧光原位杂交. j8 V  l1 e$ ]+ @* E6 a1 }( Z2 `* j
FMF:familial Mediteranean fever,家族性地中海热
( H# ]5 @7 g+ OFoley catheter:弗利氏导尿管,气囊导尿管
3 j: a$ ~' `- E  k0 j( R9 jFrTBI:fractional total body irradiation,分次全身照射
& @3 P! b1 W2 z# JFSRC: 胎羊体内增殖的人造血干细胞% a3 ?6 b/ v$ {5 s. ~
Fungus:真菌 2 }) _. o% T0 x+ z4 z0 J, S) Y
Fungi: Fungus复数形式
7 P+ U8 O! j+ j* eG6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶
# I# L3 x( u4 Z/ b/ D& m* mGastritis:胃炎 9 ?0 ~3 \8 L$ ~( W" r* x' P
Gastrointestinal:胃肠道的
. k8 t  @, z& y) j+ P4 EG-CFC:granulocyte colony forming cells,粒细胞集落形成细胞
/ ]+ z4 _) D* `6 m4 ^8 C- wG-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子
* D- O2 B$ L# ^GCV:cytomegalovirus,巨细胞病毒9 {2 d& C$ g: O0 D
GCV:ganciclovir,更昔洛韦
& I& Y- @* f+ `$ h8 |GI:gastrointestinal,胃肠道的
( j* Y  T" s: N- iGM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子 - ]; _% [$ u5 v( O  w
GM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞
% A7 u: A8 H1 d; P" @9 K6 m. jGraft rejection:移植排斥(反应)
: e# F) t# u% C/ D4 W9 O, gGraft-versus-host disease:移植物抗宿主病
  _; R4 ^, j1 Z) R4 V8 l- _Granulocyte:粒细胞 / B9 U4 H, w' u& E) c7 q
Growth factor:生长因子
" {  X& y, H* l- K+ |5 u- pGTR:granulocyte turnover rate,粒细胞转换率! c+ N* Z- U5 g+ S) t
GVHD:graft-versus-host disease,移植物抗宿主病
* v" K+ H( d2 K: ]" ^GVHR: graft-versus-host reaction,移植物抗宿主反应. f5 O4 r  h0 k+ E1 ^
GVL:graft-versus-leukemia,移植物抗白血病* Q8 s& \+ v. F: A+ b
GVT:graft-versus-tumor,移植物抗肿瘤2 Y! \  y9 f% ]7 j; C, G
Haploidentical: 半相和的
6 o- [- S- k/ m2 rHarvest: 收集,采集
1 ?: k  g, \# J0 T$ ~HC:hemorrhagic cystitis,出血性膀胱炎
  b! c7 y! ~( k$ h" aHCL:hairy cell leukemia,毛细胞白血病, f+ T* z, v0 T9 ~8 B! y) b
HD:Hodgkin's disease,霍奇金病
8 R7 d! x- r' M" VHD:high dose,大剂量. F6 T7 z: _. }3 I3 B8 {0 G
Hematocrit:红细胞压积
4 @$ g' z) U; Y3 |5 OHematology:血液学 & K% S4 H: R( ^8 C1 B
Hematopoiesis:造血作用,生血作用+ U& |% E+ y( Y) u6 b
Hematopoietic system:造血系统
  N7 [! C0 U0 l7 v) |7 M( K- J1 m, VHemoglobin:血色素,血红蛋白
8 h1 `/ W' M& V& S, S9 I4 V# j- cHemorrhage:出血
* R) p* Z. `- R, r8 J" }( cHemorrhagic cystitis:出血性膀胱炎
4 P. W8 ]! K! ?Hepat - :(前缀)肝的
4 j; d. R+ {- F3 D# t' {, pHepatitis:肝炎
* U$ y+ J9 t% S5 R* x. D9 F' BHES:hypereosinophilic syndrome,高嗜酸粒细胞综合征
0 ]* P% R. Y# u4 H5 ~0 RHGF:hematopoietic growth factor,造血生长因子9 v. `* r( b2 A2 c+ u
HHV:human herpus virus,人疱疹病毒/ S/ P% N5 P5 w9 d+ c/ T% c
Hickman catheter:Hichman导管,中心静脉插管
, g: k5 `$ w& b  o4 c* @HIV:human immune deficiency virus,人免疫缺陷病毒
8 @, Q+ ]* |: Z' NHLA:human leukocyte antigen,人类白细胞抗原 & j) ?1 d# H1 J+ c! s8 F
HLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症
3 X2 M% k+ z+ s( THMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症
# q5 e8 v; q2 n" `2 t$ fHomogenic transplantation:同基因移植6 Y9 m( Q% v* m1 l' v$ S
Homozygote:纯合子: U1 Z: F1 f5 m: z& D8 Y* e# f
HPC:hematopoietic progenitor cell,造血祖细胞" r/ T& p, [3 O7 K
HPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位
+ y1 q$ t8 |; X# q. s2 IHR-ALL:high risk ALL,高危型急性淋巴细胞白血病
4 ]/ N' E; S  M9 SHSC:Hand-Schuller-Christian disease,韩-薛-柯病! U9 B; n7 E. i. v1 c
HSC:hematopoietic stem cell,造血干细胞0 [) e6 J( f7 a! @4 w
HSR:homogenously staining region,均染色区" z8 B: I! S' e+ @/ l, C  n; L# b
HSV:herpes simplex virus,单纯疱疹病毒
: y+ {; n2 G* H! J) b0 lHTC: typing cell,纯合子分型细胞
% q* n! f+ j, d* {$ JHTLV:human T cell leukemia virus,人类T细胞白血病病毒& ?' o$ O7 x6 o5 W, v
HVOD:hepatic venous occlusive disease,肝静脉闭塞病  |. C% G# h/ M/ w: P, X
Hyper- :(前缀)高,超,(过)多
- N/ d: R9 @+ @# N9 i8 GHyperalimentation:高营养支持,静脉高营养; s9 B' y9 P. F. m, q- D
Hyperpigmentation:色素沉着过度
6 P& p& h0 q4 b' k9 E7 a3 LHypertension:高血压 : p0 R: o, `1 D$ y
Hypo- :(前缀)(过)低,少于  _9 x% C6 X. F
Hypotension:低血压
. \  X0 h; p( Y& i; u2 a$ BIAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征) M' O* a4 s) {& J
id:medium dose,中剂量" G' |, l5 M- N) m& R3 w
id:initial dose,初始剂量& Y9 }; K; I- |1 T+ @9 ~1 B6 ]5 n8 c
IF:involved field,累及野( w5 C4 n( G& `) {6 z
IFN:interferon,干扰素
  l% E) s# e3 z( y7 Q; p$ DIg:immunoglobulin,免疫球蛋白 * z6 N5 d; s! Z$ s  ?
IGFs: insulin-like growth factor,胰岛素样生长因子" u5 U" J' d4 H) D7 i& H# H
IgH:immunoglobulin heavy chain,免疫球蛋白重链
! M* H' N' ~) s' CIL:interleukin,白细胞介素8 z+ I  f; `' ~$ N+ ~$ q& j
Iliac crest:髂嵴
1 S+ M) s/ ^% {9 i, ?; w( YI.M.:intramuscular,肌肉注射0 ]6 K% c% R& Y% h) b7 u
Immune system:免疫系统
) H$ y0 j* T% B/ d2 UImmunocompromised:免疫受损的 ' T5 {$ d! D! G8 F: R
Immunoglobulin:免疫球蛋白
# k1 f# ^! ^) L3 R' t' o/ S; aImmunological tolerance:免疫耐受
# A, @/ ]5 j6 d( u8 o% M# F- ~Immunosuppression:免疫抑制 ; a/ b4 P9 y! z( d0 K  y
Incubation:孵育
# l' Y, P! ?: w6 ]* z2 R" |7 ?! Tinformed-consent:知情同意
$ q! ?( \; \" i1 q- _- gIntravenous:静脉内的( G! v+ F8 t& I8 W2 X' g9 F
inv: inversion,倒位
/ p7 k8 T, k8 H1 rin vitro: 体外,离体
) `: b2 S( q5 e3 a( J8 D- pin vivo: 体内2 B2 o2 U! h$ q* E) v
IP:interstitial pneumonia,间质性肺炎
  l6 ~$ |7 ?3 E- ]$ J/ c/ ?Isolation: 分离
( T7 n7 u6 g3 y- D2 G+ EI.T.:intrathecal injection,鞘内注射
" |+ J- }2 V: `7 E( T8 `-itis:(后缀)炎症 2 r! k& F$ A, N
ITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜8 k& L) l7 r1 x; K
Jaundice:黄疸- s. s6 o  y8 Z6 E. V
KPS:Karnofsky score, Karnofsky评分$ I1 d! v8 {5 F9 W0 x- {
LAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)
, p+ M. U6 i0 K) H) \- L3 x9 ?Laminar air flow unit:层流间 1 g9 }+ m( L8 `' J) h
LCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症1 Y' r7 A, F; Y% ]) }2 s- g
LD:lymphocyte depletion,淋巴细胞消减型
3 L0 L9 n! j! p8 z3 \LD:low dose,小剂量
' u# q7 w* c/ ?# T* J) x2 N+ zLDH:lactate dehydrogenase,乳酸脱氢酶# [% L7 T' y" g0 y8 P: o( I8 E: \
Leukapheresis: 白细胞采集物
1 R6 t- I7 Q. {7 U7 OLeukemia:白血病 ) O# A3 e) o0 V" ^2 z: U: q9 a
Leukocyte:白细胞+ K' @* Y: H6 }
Leukopenia: 白细胞减少症
7 ~. u* `7 [  x$ n6 Z1 Q4 g2 pLFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原
" r; }. E3 V$ oLFS:leukemia free survival,无白血病存活期0 s  T) l$ N7 C% H
LGL:low grade lymphoma,低度恶性淋巴瘤4 ?  E  A2 W1 q+ n" C( w
LHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体# v! l" o1 j+ U1 \3 O
LI:labeling index,标记指数  J; _2 c4 l0 F
LIF:leukemia inhibition factor,白血病抑制因子
0 x* _5 w) R) cLineage:系6 O: Q0 v8 C* x
LOH:loss of heterozygosity,杂合性丢失
, G5 f0 Q! S2 v) x- r- B1 M: G9 BLP:lymphocyte predominance,淋巴细胞为主型6 {% c# `3 g& A4 }7 Y7 C) w
LRP:lung resistance related protein,肺抗性相关蛋白
& f  b: Z1 H' I, y* `! m, F2 XLTB:life-threatening bleeding,致命性出血
5 Q$ z* Y1 U" D# ]LTC-IC:long-term culture-initiating cell,长期培养起始细胞8 l# q; r3 T2 A. r. Q; |. R5 m
LTR:long terminal repeat:长末端重复序列# h5 D6 G) {# h$ z3 T- C' r2 l7 V
LVL:large volume leukapheresis,大容量白细胞单采
) {( Y% v" W6 E. p6 C6 ]$ ZLymphocyte: 淋巴细胞
4 P1 t  z" j9 _4 \! Q2 p6 ?0 tMacrophage:巨噬细胞. [% y" r# M4 N" C* N' x$ V
MACS:magnetic activated cell sorting,磁性活化细胞分选1 [0 A) C: d/ T+ _1 _5 @* |# P! W
MAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞). X3 W3 {5 R& T! d  Y' g
Malabsorption:吸收障碍
& V. V1 o+ \  s, @* [MALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷- V! o0 s2 b- D& }* `
Matching:配型
+ L  q( D* r- EMBDI:marrow blast decline index骨髓原始细胞减少指数
( i- {- o( F2 M4 x9 YMC:mixed cellularity,混合细胞型
; a2 ?- U' W* `" E, F, S! A0 RMcAb:monoclonal antibody,单克隆抗体5 v# C* x" t8 M
mCR: median complete remission,中位完全缓解
+ O$ a/ B7 A3 c. KMDR:multiple drug resistance,多药耐药
/ w( e  ]; C% {. |MDS:myelodysplastic syndrome,骨髓增生异常综合征
2 }3 P8 Y# [: U) N! kMegakaryocyte:巨核细胞
2 |: j, a! `$ r: n9 _: F, `7 C" MMetabolite:代谢物 ! h& ?9 \+ B) g+ z
Metastatic:转移的 , v* n* S  f" {5 G; F( z6 V4 O+ n3 c4 A) j
MF:myelofibrosis,骨髓纤维化+ u/ }$ c/ M' B! U4 j3 F0 S
MF:mycosis fungoides,蕈样霉菌病& J0 Y5 X- d! Z5 r
MGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子
3 Y: @( j2 n% y& w1 C: fMGP:marginal granulocyte pool,边缘粒细胞池( f  ^' P! S; G2 }0 q4 o
MGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症7 C' R' U2 n* L$ s9 C/ Y6 W
MH:malignant histocytosis,恶性组织细胞增生症
( ^2 T! E9 |5 B9 bMHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统7 l2 D! a- s+ E% |/ C+ F, b
MHC:major histocompatibility complex,主要组织相容性抗原复合体
* |$ N" q1 J6 J6 K1 W7 Q" |: RMLC:mixed lymphocyte culture,混合淋巴细胞培养
, b; p+ X% L) s% ?MLL:mixed lineage leukemia,混合系白血病
/ J4 d7 B# {# ~' yMM:multiple myeloma,多发性骨髓瘤
/ N$ [7 ^, Z* C6 g- S8 H! Q- j3 `MNC:mononuclear cells,单个核细胞
+ x, {/ h  @3 @6 UMobilization:动员' A% W3 @5 H4 z& R
Monoclonal antibody:单克隆抗体
& U. F5 Y7 M; W' _6 wMonocyte:单核细胞
  P0 k& y5 g/ N, b  KMonozygotic:单合子的
7 b2 G- P9 t  }- Z( Q0 @$ ZMorbidity:发病率 7 P; c/ Q: b, t# L+ f
MPD:myeloproliferative disease, 骨髓增殖性疾病
6 `( k8 @5 q2 Y3 x6 T; }( H# xMPO:myeloperoxidase,髓过氧化物酶
/ |# Q- @0 F" ^! U# n' J; N2 @MRD:minimal residual disease,微小残留病变
) l3 d# q$ l1 |& J: Y( tMRP:multidrug resistance-associated protein,多药耐药相关蛋白
9 Y2 l( D( b( e3 x* n) a; ?Mucositis:粘膜炎
7 e9 K) D3 Q; A6 {$ ~; oMUD:matched unrelated donor,非血缘关系配型相合供体! |# o% i( A  n3 l8 i! b
NAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶. V8 s$ l* P9 L6 H9 c# b) j" S* ^
NB:neuroblastoma,神经母细胞瘤7 s5 j8 L1 }2 G! X
NBM:normal bone marrow,正常骨髓' }; t, `7 @) A& Z7 \! [
Negative selection:阴性选择8 v1 N7 e1 Y( a: N1 v
Neuro- :(前缀)神经的- J$ E# _2 N# V' O; ^6 N+ ~
Neutropenia:中性粒细胞减少症 " I" n- I1 A; g5 n/ o. x
Neutrophil:中性粒细胞 * l6 }5 h; [# O8 @7 q
NG:neutrophil granulocyte,中性粒细胞
9 s3 h/ J! ^2 `  W- gNGF:nerve growth factor, 神经生长因子% k- D+ O3 ~: K& Z
NHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤
5 ]: L. {. c" p) c5 b1 sNK: nature killer cell,自然杀伤细胞
0 x, H2 ?% H: W8 }. w- m* ?- `Nonmyeloablative transplantation: 非清髓性移植: O" w1 M: h* h9 l1 ]
NPO:不能进食 1 b" ?+ M, Q( P5 V: H$ `- Q
NS:nodular sclerosis,结节硬化型
) M; Q  Z0 U9 j' q; W) Z  n' HOncology:肿瘤学 ' [6 y, W0 I8 X/ O5 p  w: K- q
Oto- :(前缀)耳的& f4 Z( F1 B# n7 q4 `! c3 U+ V% v
PA:plasminogen activator,纤溶酶原激活物9 F- Y  P5 [2 v# F. q
Packed red blood cells: 压积红细胞
8 F1 q9 J8 W; g6 F0 BPAE:post antibiotic effects,抗生素后续作用+ N- l0 c/ L; Q4 v
PAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂
( v0 ^& U7 K5 r3 ^1 APalliative:减轻的,缓解的 . p( D; r" p& o' F/ b0 z
palliative care unit (PCU):终末期病房,临终关怀病房7 y$ p; U5 q& @
Pancytopenia:全血细胞减少症 $ v; ]' t1 {: ~. A6 T% q
-pathy:(后缀)病 / O" r9 ]/ ~( l  i" I
PB:peripheral blood, 外周血) h+ ~5 }* t; R6 _0 E' ^$ d2 h: v
PBL:peripheral blood lymphocyte,外周血淋巴细胞$ T. ?) g3 T' r2 ?* L7 I' ~
PBPC:peripheral blood progenitor cell,外周血祖细胞
- K' Y2 ~3 y! {. u5 W& }8 `PBSCT:peripheral blood stem cell transplantation,外周血干细胞移植' z' V+ \& J* m& y
PCA:procoagulant activity,促凝活性物质. b8 a7 f1 K9 v. o8 G* \; {
PCD:programmed cell death,细胞程序化死亡
% d! P) H6 f1 F  U! Q: _' Q/ rPCL:plasma cell leukemia,浆细胞白血病  M  W8 k5 q2 A: C
PCLI:plasma cell label index,浆细胞标记指数) ]  T9 F$ Z/ E
PCR:polymerase chain reaction, 多聚酶链反应
% b- r- |" o7 s" Y! JPCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析0 X' ]8 ^. S8 a3 s6 k# }) R
PCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交
$ a2 g3 ]2 W! D( }3 tPDD:percentage depth dosage,百分深度剂量
6 u; n, |" v2 a) F$ d6 rPDGF:platelet derived growth factor,血小板衍生生长因子
# b! z, V, N7 C8 _PDR:primary drug resistance,原药耐药
6 U$ Q5 a; _1 a9 p; ?/ ^PE:plasma exchange,血浆置换
* \* ]. h3 o+ p4 T; q-penia:(后缀)缺乏,不足 ' m$ t5 H9 m) \9 l, b9 R
Peripheral neuropathy:周围神经病变 # ^. X/ z9 w* A$ C, e" n$ L
Petechiae:瘀点,瘀斑 1 q4 M: p: `% y8 V3 S7 h
Pfu: plaque forming unit,空斑形成单位
$ p5 ]* `+ L- TPHA:phytahematoagglutinin,植物血凝素6 ~" M/ |0 b4 B; p$ o7 o( S
Phlebitis:静脉炎 . r7 \; x0 I6 U  O' q3 k: b5 b
PHSC:pluripotential hematopoietic stem cell,多能造血干细胞
! J3 H3 d  i; J7 v& N- t-plasia:(后缀)发展,形成
3 U9 m9 ]4 h, ~& WPlasma:血浆
+ l( I  s' Y2 R' h( {& B$ v5 C  H( {Plasma cell: 浆细胞 4 x, |) ]2 L9 x! s0 I1 |7 j; t# r
Platelet:血小板
, ^7 N: m) @/ Y4 V, PPLG:plasminogen,纤溶酶原
9 v" x: G( Q! ^0 U' U5 KPLL:prolymphocytic leukemia,幼淋巴细胞白血病$ e8 o/ O+ r( H+ G* i* n5 i5 t, Z" l( @
PLT:platelet,血小板! l! M3 E' d/ X
PLT:primed lymphocyte test,预致敏淋巴细胞试验
7 e, u: q5 y$ l7 V+ l) ]PMN:polymorphonuclear leukocyte,多形核白细胞
/ m9 y. D* k: gPNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷( s  }9 v" R6 |% r6 u
PNRE:p53 negative response element,p53阴性反应元件
# H1 n/ P6 j" B' z. c0 H9 JPOD:PML oncogenic domain,PML癌基因结构域$ Y4 ^; }+ \, {# `. `
Polycythemia:红细胞增多症
  j3 k+ _! v, _$ s) c& ], XPositive selection:阳性选择/ u+ x, j* c+ W# C+ Y2 c' L* E
PPSC: pluripotent hemotopoietic stem cell,全能造血干细胞6 X! \" f! o# ~7 P2 |
Preparative regimen:预处理方案
, |8 q+ z* h) g3 k& m4 M# `Progenitor:前体,祖先7 o, b& @5 R4 d7 @; k1 z1 x
Prognosis:预后
2 i7 Z$ E' B: Y, C, \6 L% h$ N: PProphylactic:adj.预防的;n. 预防性,预防药
2 ]+ \! S7 j" h- _* q% `$ p, o, PProphylaxis:预防法,预防
) \( |9 @! Z" J% d* rProtocol:草案,协议,治疗方案 . W5 v. j+ n7 N& ^0 @+ s; P8 X; R, i
Proto-onc: proto-oncogene,原癌基因" X, d" E) L8 R. R/ K# X: S
PSS:posterior superior spine,髂后上棘
9 e  P; n1 I: E$ x1 TPT:prothrombin time,凝血酶原时间
1 h7 x6 G5 z. |4 v. f7 DPTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤' d0 M0 c/ y) E# g' j# E; g
PTH:post-transfusion hepatitis, 输血后肝炎5 n6 m. K& _) g5 g, v
Pulmonary:肺的
" M: t9 E5 f1 \# S' I! w; QPurging:净化
" Q. d- \0 e# O2 PPurity:纯度
3 e0 O9 a5 f9 Q1 t' E7 H" F, |; rPV:polycythemia vera,真性红细胞增多症
/ q  l, d+ \' Z) @Quality of Life (QOL):生活质量' Q! \$ \& F" g. \/ N6 D
RA:refractory anemia,难治性贫血 $ t# M( Z5 ?1 [0 t
RAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型
5 d5 E% A  L0 h: oRAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型7 y3 x/ h/ N, q
RAR:retinoic acid receptor,维甲酸受体: c. U+ Z" o0 e% d1 B
RAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多
4 P$ q: P# H, HRAS:retinoic acid syndrome,维甲酸综合征; s) ]0 \0 K  j5 n
RB:retinoblastoma,视网膜母细胞瘤
, m5 i8 q0 l9 H5 t" gRBC: red blood cell,红细胞
2 N7 {) x. Z4 n- Z% cReagent:试剂4 u% R( k0 m) v* |/ J
Recipient:受者
4 u' k. C9 H: T) z  Z. k/ jRejection:排斥
1 ?) |5 o4 }/ t, mRelapse:复发 . o4 d( g+ e/ [9 N+ M& h/ U
Remission:缓解
4 b% m  d, T! v! E( |5 HRenal:肾脏的,肾的
# ?: @3 z( o, K& r5 z( {4 P. v. DRFS:replase free survival,无复发生存
- E" c3 f+ F$ E5 \9 t$ NRPC:radiation protective competence, 辐射保护能力
2 x5 @) P1 k7 o: \! w# vRegimen-related toxicity (RRT):预处理相关毒性
' X+ `1 l( l9 w- rRT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应
# ^. I7 O+ L& q, Y3 dSBB:sudan black B,苏丹黑B$ l' Y7 i3 k5 ]+ i& L
SCE:sister chromatial exchange,姐妹染色单体交换! n, d3 T8 U: d3 u# ?9 m5 j/ q
SCF:stem cell factor,干细胞因子
, A8 _. y8 P4 ~, wSCid:severe combined immunodeficiency disease,重症联合免疫缺陷7 Z0 ^! I" D! o+ |1 S
SCL:stem cell leukemia,干细胞白血病% s+ T9 q* g$ P% ~9 s. [
SE:specific estarase,特异性酯酶  Z* N+ Z  f1 i9 y. d( O
Selectin:选择素! F( \6 v* f3 m5 Q
Sense primer:同义引物; K; }* O" \6 P/ m& `) x" T# \
Separation:(细胞)分选; _6 }: W/ i2 n1 l& C
Sepsis:脓血病,败血病
' P- i5 K2 D2 @Sequencing测序
1 s# ]$ f( w$ M9 h. y% vSF:serum ferritin,血清铁蛋白' O/ m! W8 z! Q4 g8 T  d9 M) s3 E
SHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大
8 F8 x8 _( w) ~7 {! vSIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法5 m$ b( f3 r% ~/ s8 P. ^
SLE:systemic lupus erythematosus,系统性红斑狼疮- r& B8 [3 a- ?8 M: g  d
SLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤
* B; }5 q4 \0 O0 y3 r% K# hSolid tumor:实体瘤
$ C* b8 `* ?" e0 I7 e; G: Y7 f! SSR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病! R/ e- t% z% }0 j
SRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞
+ O$ ~8 s: E9 N- qSS:Sezary syndrome,Sezary综合征
7 Y: L) K  y4 t, C4 C* TStem cell:干细胞+ d; o" `2 r' f( T4 B/ T9 M
STNI:subtotal nodal irradiation,次全淋巴结照射
% v) k- F: z8 s/ G3 {) IStomatitis:口炎
# x+ @0 e  k( i$ Q& j/ CSubclavian catheter:锁骨下导管 . W! K8 G" U7 R7 G' E- z- a
Supernatant:上清! {4 |7 I7 [- |3 d
Syn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植
( R$ U3 H" {# u& ASyngeneic:同基因的
0 @  K" k* h% z7 S# STAM:tumor associated macrophage,肿瘤相关巨噬细胞
# i6 e: P- q, k4 |7 Y# @) \4 Lt-AML:treatment associated AML,治疗相关的急性髓性白血病
' Z" u3 X/ K5 YTA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病! k7 @: E# C; s: H8 @
TAA:tumor associated antigen,肿瘤相关抗原
# X/ g% c" _: _: k9 j% PTBGP:total blood granulocyte pool,总血液粒细胞池" r; l$ h6 S4 W6 c
TBI:total body irradiation,全身照射+ k& h! B9 {% S7 j
Tc:time of cell cycle, 细胞周期时间4 `1 ^0 |/ t1 J. c) G# H
TCD:T cell depletion, T细胞去除& O9 W7 B) x$ e9 [/ }) e  U8 G
TCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤 ) a; o  _4 M3 }1 H# I( E
TCR:T cell receptor,T细胞受体
& Q; Q# _# i- ?7 k3 W( \; {TCS:tumor cell survival,肿瘤细胞成活( d6 V3 Y+ T1 n; U1 ~* V
TEN:total enteral nutrition,完全胃肠内营养% X' [9 v' o1 L5 G+ O
TF:tissue factor,组织因子5 E/ R1 F# H' l
TF:thymic factor,胸腺因子
1 v* \5 \# h: [9 f7 U/ H& fTFPI:tissue factor pathway inhibitor,组织因子途径抑制物
# H2 Q/ J! R$ n6 [1 I7 CTGF:therapeutic gain factor,治疗获得系数
8 N% @5 Q; H& |3 cTGF-β:transforming growth factor-β,转化生长因子β
0 @) s7 x* _$ W, y5 P6 w( rThrombocyte:血小板
& r2 ?* _6 P- O/ N' R1 k5 G" EThrombocytopenia:血小板减少症
$ ?1 Z- V% B# b+ J% R: ~9 \( mTIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞$ T3 A& G' B- ?
TL:testis leukemia睾丸白血病! ?' K# U* r1 ?. E2 }. _6 a; T
TLI:total Lymphoid irradiation,全淋巴照射
2 u$ d: Y, z4 g+ G0 YThrombotic microangiopathy (TMA):血栓性微血管病, m1 D) ]4 K0 J9 {
TNF:tumor necrosis factor,肿瘤坏死因子
3 M9 Y) q( C9 K  ?* Y4 u" B$ f* zTNI:total nodal irradiation,全淋巴结照射
2 u/ r# c5 \+ X0 m. b5 W0 YTOPO II:topoisomerase II,拓扑易构酶II- l1 ~5 ]7 r+ `
Toxin:毒素
- U$ @/ g9 f+ ~' X* e  `8 F+ t. LTpdt:potential doubling time,倍增时间2 f4 N# S& M) l9 G! K, M1 G1 C4 ]# P1 j
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病
2 C7 m8 o, k" j7 }) K2 f1 PTPN:total parenteral nutrition,全肠道外营养,静脉高营养
3 ]' P" e# |1 m4 p* lTPO:thrombopoietin,促血小板生成素
3 L/ U3 j( B( W% ]4 G  KTPS:treatment planning system,治疗计划系统
% d1 ~5 u6 y3 j9 |2 v9 N' m& TTranslocation:易位% Z4 z" r1 A( O* J
Trauma:创伤
' ]9 x. j' j! ~6 y  T& UTRM:transplantation related mortality,移植相关死亡率# o! F6 N; n+ ?' [+ }0 K0 w/ A
TSC:timed-sequential chemotherapy,时相序贯化疗2 {, I" I- H, v( V0 d
TSPA:triophosphoramide,噻替派# j9 s4 G3 Z8 B6 X
TTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜* ~. J1 u3 R5 c. b" s4 H) X* H
Tumor:肿瘤
; Y8 L: S) H: j2 mTumor burden:肿瘤负荷
0 h" Q3 J  d' o8 \0 Q- EUCB:umbilical cord blood,脐带血, r* W$ k* M9 {+ r# C
Ultrasound:超声
/ K) g0 f5 b) `$ t$ rUmbilical cord:脐带
9 Q" o7 \1 M' y2 w0 }( m, r% {5 \VAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征
5 H/ H' ?. T  d# }& ~2 o) cVGPR:very good partial remission,非常良好的部分缓解
2 F$ e6 j% P" j% L* C0 c/ ^& uViability:活性0 d+ r4 i+ P' }$ [, G
Virus:病毒 6 ?! }3 U& V; Q* `* L, U
VOD:veno-occlusive disease,静脉阻塞性疾病 # C+ {. M; i7 U& \$ }
v-onc: virus oncogene,病毒癌基因
8 d! T( o3 `. G% x) L. O3 GVPF: vascular permeability factor,血管渗透因子1 N& {4 p8 Z5 @: Y- a5 y6 [
VZV:varicella zoster virus,水痘带状疱疹病毒
) q! i$ J9 M: o* T) M) w9 oWBC:white blood cell,白细胞 0 X- C3 F7 [( v( h8 Z# x" o
Whole blood:全血
: _  u6 b: T+ w/ U5 M& I- c, ^WT:Wilms tumor,肾母细胞瘤' [. O2 {3 j) k7 A4 g: j
Xerostomia:口腔干燥症
6 B; K# y, ^1 H8 GYield:产量




欢迎光临 干细胞之家 - 中国干细胞行业门户第一站 (http://www.stemcell8.cn/) Powered by Discuz! X1.5